INVO Bioscience and NAYA Biosciences Merger Under Investigation for Shareholder Fairness
INVO Bioscience and NAYA Biosciences have entered into a definitive merger agreement for INVO to acquire NAYA in an all-stock transaction. The combined company, operating under the name "NAYA Biosciences," aims to increase patient access to life-transforming treatments in oncology, fertility, and regenerative medicine. The merger will allow NAYA to strengthen INVO's fertility operations, expand its network of fertility clinics, and advance the development of NAYA's clinical-stage portfolio of oncology therapeutics. The transaction is subject to shareholder approval and other closing conditions and is expected to close in Q4 2023.
